Compugen CGEN
NASDAQ CGEN
$2.09 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Compugen (CGEN) Liabilities from Discontinued Operations (2009)

Updated

Compugen (CGEN) recorded Liabilities from Discontinued Operations of $12,000 in Q2 2009, unchanged from the prior quarter.

Analysis

Compugen (CGEN) Liabilities from Discontinued Operations (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Compugen 197.62 Mn -218.36 Mn 1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2009 12,000.00
Mar 31, 2009 12,000.00
API Access

Compugen Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=CGEN&period=max&api_key=YOUR_API_KEY